v3.26.1
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
May 01, 2026
Mar. 16, 2026
Mar. 03, 2026
Feb. 06, 2026
Feb. 01, 2026
Dec. 30, 2025
Sep. 05, 2025
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Jan. 22, 2026
Dec. 29, 2025
Sep. 04, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during the period, shares         3,750,000                        
Exercise price                         $ 0.85        
Granted shares                         250,000        
Weighted average exercise price                         $ 3.21        
Weighted average remaining contractual term                         10 years        
Share based compensation                 $ 3,953       $ 7,862        
Unrecognized compensation cost $ 0               $ 0       0        
Grant date fair value per unit                             $ 3.00    
Share based compensation expense                         $ 32,487 $ 14,194      
Weighted average period                         1 year 4 months 28 days        
Share based compensation, granted                         6,562,741        
Stock issued grant fair value                       $ 3,882          
Share based payment based description                         The executives’ employment agreements also provide for one-time awards upon the Company achieving market capitalization milestones of $50 billion, $100 billion, and $500 billion, based on a 30-day volume-weighted average price.        
Share based compensation, granted                         5,590,000        
Unrecognized compesation cost write off period                         7 years 4 months 24 days        
Stock issued during the period, other                       $ 818          
Third Party Consultant [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during the period, shares     1,000,000                            
Viral Clear Pharmaceuticals Inc [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Shares available for future issuance 2,915,071               2,915,071       2,915,071        
Minimum [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit $ 5.00               $ 5.00       $ 5.00        
Weighted average period                         3 years 5 months 4 days        
Maximum [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit $ 15.00               $ 15.00       $ 15.00        
Weighted average period                         8 years 10 months 2 days        
Two Service Providers [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Share based compensation, granted                         900,000        
Third Party Consultant [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Share based compensation, granted           500,000                      
Third Party Consultant [Member] | Minimum [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit           $ 5.00                      
Third Party Consultant [Member] | Maximum [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit           $ 12.00                      
Nonemployee Service Provider [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Share based compensation, granted       400,000                          
Nonemployee Service Provider [Member] | Share-Based Payment Arrangement, Tranche One [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit       $ 5.00                          
Nonemployee Service Provider [Member] | Share-Based Payment Arrangement, Tranche Two [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit       6.00                          
Nonemployee Service Provider [Member] | Share-Based Payment Arrangement, Tranche Three [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit       7.00                          
Nonemployee Service Provider [Member] | Share Based Compensation Award Tranche Four [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit       8.00                          
Nonemployee Service Provider [Member] | Share Based Compensation Award Tranche Five [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit       10.00                          
Nonemployee Service Provider [Member] | Share Based Compensation Award Tranche Six [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit       $ 15.00                          
Chief Investment Officer [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during the period, shares   3,000,000                              
Common Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during the period, shares                       4,403,166          
Shares of its common stock, warrants                         54,647        
Stock issued grant fair value                       $ 4          
Grant date fair value     $ 1.83                            
Stock issued during the period, other     $ 3,500                 $ 1          
Warrant [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Warrants to purchase common stock 87,984               87,984       87,984        
Grant date fair value per unit $ 0.85               $ 0.85       $ 0.85        
Share-Based Payment Arrangement, Option [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Share based compensation                 $ 0   $ 1,036   $ 770 1,076      
Share-Based Payment Arrangement, Option [Member] | 2023 Long-Term Incentive Plan [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during the period, shares 11,679,915           22,494,324 10,359,211                  
Shares authorized             37,230,130 14,735,806               14,735,806 4,376,595
Restricted Stock Units (RSUs) [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Share based compensation expense                 7,136   $ 11,068   31,681 $ 13,057      
Unrecognized stock-based compensation cost $ 19,899               $ 19,899       $ 19,899        
Share based compensation, granted                         12,152,741        
Stock issued grant fair value [1]                         $ 9,680        
Restricted Stock Units (RSUs) [Member] | Viral Clear Pharmaceuticals Inc [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Share based compensation, granted                         12,152,741        
Performance Vesting Restricted Stock Units [Member] | Employment Agreement [Member] | Chief Executive Officer [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Number of shares granted   1,500,000                              
Performance Vesting Restricted Stock Units [Member] | Employment Agreement [Member] | Executive Chairman [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Number of shares granted   1,500,000                              
Performance Vesting Restricted Stock Units [Member] | Capital Units [Member] | Employment Agreement [Member] | Executive Chairman [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit   $ 1.18                              
Grant date aggregate fair value of performance units   $ 3,540                              
Share-Based Payment Arrangement, Tranche One [Member] | Employment Agreement [Member] | Chief Investment Officer [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued grant fair value   250,000                              
Share-Based Payment Arrangement, Tranche Two [Member] | Employment Agreement [Member] | Chief Investment Officer [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued grant fair value   500,000                              
Share-Based Payment Arrangement, Tranche Three [Member] | Employment Agreement [Member] | Chief Investment Officer [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued grant fair value   1,000,000                              
Share Based Compensation Award Tranche Four [Member] | Employment Agreement [Member] | Chief Investment Officer [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued grant fair value   2,000,000                              
Share Based Compensation Award Tranche Five [Member] | Employment Agreement [Member] | Chief Investment Officer [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued grant fair value   $ 3,000,000                              
Performance Shares [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during the period, shares                         900,000        
Stock issued grant fair value                         $ 1,778        
Stock issued during the period, conversion     $ 1,830                            
Number of shares awarded 300,000               300,000       300,000        
Performance shares units 910,000               910,000       910,000        
February And March Performance Shares [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued grant fair value                         $ 2,605        
February Performance Vesting Restricted Stock Units [Member] | Capital Units [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit   $ 3.56                              
Grant date fair value per unit   2.07                              
March Performance Vesting Restricted Stock Units [Member] | Capital Units [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Grant date fair value per unit   $ 827,000                              
February Performance Shares [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Share based compensation expense                 $ 54 $ 54              
March Performance Shares [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Share based compensation expense                 27       35        
February And March Performance Stock Units [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Unrecognized compensation cost $ 792               $ 792       $ 792        
AUM based PSU [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock option description     (i) 50,000 units upon fund launch, subject to a dollar cap of $150; (ii) 100,000 units when AUM exceeds $500 million, subject to a dollar cap of $350; and (iii) 850,000 units when AUM exceeds $1 billion, subject to a dollar cap of $3,000.                            
[1] Grant-date fair value (“GDFV”)